Rheumatoid arthritis can turn everyday movements into painful hurdles. When widespread joint stiffness, swelling, and persistent pain hijack your daily life, finding relief often requires looking beyond traditional, localized treatments.
Dezawa MuseCells® IV therapy is a breakthrough in regenerative medicine that addresses the systemic nature of rheumatoid arthritis. Discovered by Dr. Mari Dezawa, these unique cells act as the body’s natural first responders, circulating through the bloodstream to actively seek out inflammation and promote tissue repair. For arthritis patients dealing with body-wide pain, this intravenous approach represents a potential path forward.
This guide explains the science behind Dezawa MuseCells® and explores whether IV therapy can help you reclaim your mobility.
Why Are Patients with Arthritis Looking for Alternative Pain Relief?
Rheumatoid arthritis creates a complex inflammatory environment within and around affected joints. Pain may persist in multiple areas of the body and be accompanied by stiffness, swelling, and movement limitations.
Patients exploring regenerative medicine often seek approaches that interact with inflammatory and tissue-repair processes at the biological level.
A person with rheumatoid arthritis may experience:
- Persistent pain in multiple joints
- Morning stiffness
- Swelling and tenderness
- Reduced grip strength
- Difficulty walking or exercising
- Loss of mobility
- Pain that continues to affect daily activities
What Are Dezawa MuseCells®?
Muse stands for Multilineage-Differentiating Stress-Enduring.
Dezawa MuseCells® are a distinct cell population with characteristics that include stress tolerance, self-renewal, and multilineage differentiation potential. Research has also examined their anti-inflammatory, immunomodulatory, and tissue-supporting activity.
The Dezawa MuseCell® Biological Connection to Arthritis Pain
The current body of Dezawa MuseCell® research points to several biological characteristics particularly relevant to those experiencing persistent arthritis pain.
| Muse Cell Characteristic | Potential Relevance to Arthritis Pain |
| Tissue homing | Muse cells respond to biological signals associated with tissue injury. |
| IV delivery | Allows systemic circulation rather than focusing on one joint. |
| TGF-β secretion | Associated with regulation of inflammatory and pain-related processes. |
| IL-10 secretion | Supports anti-inflammatory signaling. |
| Immunomodulatory activity | A key area of interest in inflammatory conditions. |
| Stress tolerance | Allows Muse Cells to survive challenging biological environments. |
| Multilineage potential | Relevant to broader tissue repair and regenerative medicine research. |
IV Dezawa MuseCell® Therapy For Multi-Joint Arthritis Pain
Rheumatoid arthritis rarely behaves like a simple isolated injury.
A patient may experience pain in both hands, both wrists, and both knees. Another may struggle with shoulder pain, foot pain, and stiffness throughout the body. Symptoms can also change over time.
A localized injection addresses one anatomical area per treatment. Dezawa MuseCell® IV therapy uses a systemic delivery model.
The systemic nature of IV delivery is particularly relevant to patients whose arthritis pain and functional limitations involve more than one joint. Instead of focusing exclusively on isolated painful areas, patients can explore whether a systemic regenerative approach may be appropriate for their individual symptoms.
As a result, IV treatment can target arthritic pain throughout the body, including:
- Shoulders: Addressing pain and restricted range of motion.
- Knees: Targeting inflammation in one or both of these major weight-bearing joints.
- Hands and fingers: Reaching the small, intricate joints where RA often first appears.
- Wrists: Alleviating the symmetric stiffness common in rheumatoid arthritis.
- Feet and ankles: Addressing pain that impacts mobility and walking.
- Hips: Targeting deeper joint inflammation that localized injections sometimes struggle to reach.
- Elbows: Reducing stiffness and swelling in the upper extremities.
- Neck and spine: Reaching widespread inflammatory pain that can radiate through the body.
Research on the Pain-Relieving Effects of Dezawa MuseCells®
Research on Dezawa MuseCell® biology has repeatedly shown how these cells circulate after intravenous administration and migrate toward injury-affected tissue. The S1P-S1PR2 pathway has emerged as an important mechanism involved in this process.
The 2026 study “Multilineage Differentiating Stress-Enduring Cells Alleviate Neuropathic Pain Through TGF-β and IL-10-Dependent Anti-Inflammatory Signaling,” published in the Journal of Biological Chemistry, examined the pain-modulating and anti-inflammatory activity of Dezawa MuseCells®. The researchers identified TGF-β and IL-10 as important mechanisms underlying the analgesic effects observed in the study.
The study also examined the inflammatory signaling produced by Dezawa MuseCells®. Compared with bone marrow stromal cells evaluated by the researchers, Dezawa MuseCells® demonstrated substantially greater IL-10 expression and secretion. IL-10 is an important anti-inflammatory cytokine, making this finding particularly relevant to ongoing interest in how Muse Cells may influence inflammatory pain pathways.
For IV therapy to relieve arthritis pain, cells must navigate to the joint damage and physically rebuild it. A 2024 study published in the Cartilage journal mapped this exact homing capability in a model of severe acute tissue destruction.
Researchers intravenously injected a small dose (50,000 cells) of Dezawa MuseCells®. The data revealed that the cells selectively homed to the injury site, survived for 8 weeks, differentiated into the exact required structural cells, and effectively rebuilt the damaged tissue walls without immune rejection.
Who Is the Ideal Candidate for Dezawa MuseCell® IV Therapy?
The ideal patient is generally someone whose arthritis-related pain continues to meaningfully affect their mobility, comfort, and quality of life and who is interested in exploring an advanced, systemic regenerative medicine approach.
A consultation may be particularly relevant for patients who have:
Persistent Multi-Joint Pain
Patients experiencing pain in several joints may benefit significantly from the systemic nature of IV-based therapy.
Stiffness and Functional Limitations
Difficulty walking, gripping objects, exercising, or completing everyday activities can have a significant effect on quality of life. A consultation can explore the patient’s symptoms and treatment goals in greater detail.
A Confirmed Rheumatoid Arthritis Diagnosis
Understanding the source of joint pain is important. Rheumatoid arthritis presents differently from osteoarthritis, tendon injuries, and isolated orthopedic conditions.
An Interest in Advanced Regenerative Medicine
Therapy is particularly relevant for patients who want to understand the science behind Dezawa MuseCells®, including their tissue-homing behavior, anti-inflammatory signaling, and systemic IV delivery.
Tried Pain-Relieving Injections Without Success
Patients with symptoms concentrated in a single area may be interested in localized treatments. Patients dealing with pain and stiffness involving multiple joints may find the systemic approach behind IV Dezawa MuseCell® therapy more suitable than local injections.
What Happens During a Dezawa MuseCell® Consultation for Arthritis Patients?
Every patient experiences arthritis differently.
A consultation at STEMS Health can include a discussion of:
- Your rheumatoid arthritis diagnosis
- The joints currently affected by pain
- The duration and severity of symptoms
- How arthritis affects your mobility and daily activities
- Your history with pain management and other treatments
- Your goals for regenerative medicine
- Whether a systemic Muse Cell approach aligns with your individual needs
This individualized approach is important because two people with arthritis can have very different symptom patterns. One patient may primarily struggle with hand and wrist pain, while another may have more significant limitations involving the knees, feet, or shoulders.
Explore Dezawa MuseCell® IV Therapy for Rheumatoid Arthritis at STEMS Health in Miami
Persistent arthritis pain can affect nearly every part of life. When symptoms limit movement, exercise, and everyday activities, patients often begin looking for approaches that address more than a single painful area.
Dezawa MuseCells® are considered the gold standard in regenerative treatment, combining systemic IV delivery, tissue-homing behavior, anti-inflammatory signaling, and multilineage potential.
If you are living with chronic arthritis pain and want to learn more about Dezawa MuseCell® IV therapy, contact STEMS Health today to book a personalized consultation.
